aap 2008: sales growth to EUR 31.2 million (+ 11%)

aap Implantate AG, a medical technology company listed on the Frankfurt Stock Exchange in the Prime Standard segment, achieved in the fourth quarter of the financial year 2008 - according to preliminary figures - quarterly sales of EUR 7.1 million (- 24% to fourth quarter 2007). In contrast to the fourth quarter 2008, the fourth quarter 2007 was influenced by more orders from global partners. Total sales of the financial year 2008 went up to EUR 31.2 million, a year-to-year increase of 11%.

In 2008, the group companies active in the field of medical biomaterials („aap bio implants group“), achieved sales of EUR 19.4 million (previous year: EUR 18.8 million, + 3%). This development is based on the considerably cautious customers’ order behavior (reduction of inventories) as well as delays in planned approvals of new products.

The Berlin based trauma & orthopaedics division of the company reached for the full financial year 2008 a strong organic sales increase of 28% to EUR 11.8 million (previous year: EUR 9.2 million).